| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $37.8M | +14.9% |
| SG&A Expense | $4.7M | +1.1% |
| Operating Income | -$42.5M | -13.2% |
| Pre-tax Income | -$38.6M | -58.6% |
| Income Tax | -$32K | -113.1% |
| Net Income | -$38.5M | -56.9% |
| EPS (Basic) | -$1.26 | -55.6% |
| EPS (Diluted) | -$1.26 | -55.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $172.7M | -13.7% |
| Current Assets | $174.6M | -13.5% |
| Total Assets | $199.1M | -12.1% |
| Current Liabilities | $15.1M | +147.6% |
| Total Liabilities | $16.8M | +116.6% |
| Stockholders' Equity | $182.3M | -16.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$31.0M | -65.4% |
| Capital Expenditures | $1.3M | +260.2% |
| Investing Cash Flow | -$1.3M | -102.1% |
| Financing Cash Flow | $10.4M | — |
| Free Cash Flow | -$32.3M | -69.1% |